A Phase 1 Study of CDX-0159

NCT04146129 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: CDX-0159
DRUG: Normal saline

Sponsor

Celldex Therapeutics